🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
18,54 USD
Máx. histórico
178,74
2142 días
Split 1:6 del 12/07/2012
Caída desde máximo
-89,63%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,20%
Cierre anterior
18,32
Rango de hoy
18,29 – 18,81
Volumen hoy
1.397.929
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,44%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 19 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/11/2023 | 81,50 | 83,11 | 79,66 | 80,10 | +2,68% | 4,23% | 2.575.900 |
| 03/11/2023 | 78,42 | 81,27 | 77,80 | 78,01 | +0,32% | 4,42% | 2.292.500 |
| 02/11/2023 | 79,43 | 82,22 | 75,69 | 77,76 | +1,62% | 8,22% | 3.736.700 |
| 01/11/2023 | 68,40 | 76,77 | 68,00 | 76,52 | +13,68% | 12,82% | 6.757.200 |
| 31/10/2023 | 57,63 | 68,00 | 55,25 | 67,31 | -37,47% | 22,12% | 23.555.200 |
| 30/10/2023 | 107,95 | 109,96 | 106,92 | 107,65 | +0,77% | 2,82% | 742.400 |
| 27/10/2023 | 111,90 | 111,90 | 106,05 | 106,83 | -4,27% | 5,23% | 928.700 |
| 26/10/2023 | 107,39 | 112,23 | 105,92 | 111,60 | +4,07% | 5,88% | 1.131.200 |
| 25/10/2023 | 112,39 | 112,66 | 106,52 | 107,24 | -5,45% | 5,46% | 1.095.300 |
| 24/10/2023 | 111,63 | 113,95 | 110,72 | 113,42 | +1,81% | 2,89% | 827.300 |
| 23/10/2023 | 111,00 | 113,42 | 109,78 | 111,40 | +0,18% | 3,28% | 869.700 |
| 20/10/2023 | 113,18 | 113,96 | 111,00 | 111,20 | -1,59% | 2,62% | 1.012.600 |
| 19/10/2023 | 114,55 | 114,99 | 111,78 | 113,00 | -0,72% | 2,80% | 753.800 |
| 18/10/2023 | 118,32 | 118,32 | 112,77 | 113,82 | -4,07% | 4,69% | 937.900 |
| 17/10/2023 | 117,00 | 119,99 | 116,57 | 118,65 | +0,94% | 2,92% | 710.300 |
| 16/10/2023 | 117,75 | 119,06 | 116,44 | 117,55 | -0,35% | 2,23% | 664.200 |
| 13/10/2023 | 116,70 | 118,73 | 114,12 | 117,96 | +0,64% | 3,95% | 780.400 |
| 12/10/2023 | 125,00 | 125,00 | 116,82 | 117,21 | -6,05% | 6,54% | 1.120.400 |
| 11/10/2023 | 122,90 | 124,85 | 122,40 | 124,76 | +1,55% | 1,99% | 781.900 |
| 10/10/2023 | 123,40 | 124,01 | 121,50 | 122,86 | -0,46% | 2,03% | 1.456.400 |
| 09/10/2023 | 122,97 | 124,10 | 121,12 | 123,43 | -0,41% | 2,42% | 1.012.800 |
| 06/10/2023 | 120,79 | 124,16 | 119,85 | 123,94 | +2,08% | 3,57% | 879.400 |
| 05/10/2023 | 117,89 | 122,66 | 117,00 | 121,41 | +3,06% | 4,80% | 1.111.700 |
| 04/10/2023 | 119,99 | 120,63 | 116,82 | 117,81 | -2,19% | 3,18% | 1.409.400 |
| 03/10/2023 | 117,97 | 121,08 | 117,71 | 120,45 | +1,57% | 2,86% | 916.400 |
| 02/10/2023 | 120,40 | 121,67 | 118,09 | 118,59 | -2,17% | 2,97% | 916.800 |
| 29/09/2023 | 124,00 | 124,10 | 120,84 | 121,22 | -1,92% | 2,63% | 782.300 |
| 28/09/2023 | 122,94 | 124,51 | 121,31 | 123,59 | +0,12% | 2,60% | 936.900 |
| 27/09/2023 | 120,52 | 124,15 | 119,34 | 123,44 | +3,37% | 3,99% | 858.000 |
| 26/09/2023 | 114,92 | 119,94 | 114,92 | 119,41 | +4,07% | 4,37% | 807.600 |